A replicon-based bioassay for the measurement of interferons in patients with chronic hepatitis C
- 15 May 2003
- journal article
- clinical trial
- Published by Elsevier in Journal of Virological Methods
- Vol. 110 (2) , 201-209
- https://doi.org/10.1016/s0166-0934(03)00134-4
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Enhancement of Hepatitis C Virus RNA Replication by Cell Culture-Adaptive MutationsJournal of Virology, 2001
- Characterization of Cell Lines Carrying Self-Replicating Hepatitis C Virus RNAsJournal of Virology, 2001
- Efficient Initiation of HCV RNA Replication in Cell CultureScience, 2000
- A Dose-Ranging Study of Pegylated Interferon Alfa-2b and Ribavirin in Chronic Hepatitis CHepatology, 2000
- Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell LineScience, 1999
- Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis CNew England Journal of Medicine, 1998
- Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfaHepatology, 1997
- Treatment of chronic hepatitis C with high-dose interferon ?-2bDigestive Diseases and Sciences, 1993
- Soluble interferon‐α receptor molecules are present in body fluidsFEBS Letters, 1992
- Treatment of Chronic Non-A, Non-B Hepatitis with Recombinant Human Alpha InterferonNew England Journal of Medicine, 1986